Stopping Drug Allergy Risks — Healware

Allergic reactions to medications affect millions of patients each year, leading to preventable hospitalizations, serious complications, and increased healthcare costs worldwide. Healware allows you to select a patient’s confirmed allergen and then enter any drug or compound to test for potential cross-reactivity. At the heart of the system is RDKit, which extracts molecular structure features and aggregates data from ChEMBL and PubChem. For each reference allergen, we train a dedicated Random Forest model, providing real-time, explainable predictions of allergic cross-reactions. The platform is currently available as a web application, and—based on user demand—we plan to launch a mobile app. Our cross-allergy project was developed in collaboration with Ukrainian physicians, medical university professors, and medical students from Ukraine to ensure clinicians have access to the most up-to-date data and recommendations. By empowering care teams with precise, data-driven insights, Healware aims to dramatically reduce adverse drug events and improve patient safety around the globe.

“We’re not just imagining the future of medicine — we’re building it. Help us bring it to every patient, everywhere.”